Making sense of the huge amount of data generated during clinical trials
The client is one of the largest pharmaceutical companies in the world. It spends hundreds of millions of dollars in clinical trials to come up with newer drugs. Clinical trials are long, expensive and their timely success is imperative for the long-term growth of a life sciences organization. For every successful molecule that passes through the clinical trials and reaches the market, there are 1000’s of molecules that do not pass through the entire cycle. Their trials are terminated during either drug discovery or development phase.